https://www.selleckchem.com/pr....oducts/crenolanib-cp
However, the limited duration of efficacy of these drugs in the field underscores the need for new and innovative approaches to discover drugs that can counter rapid resistance evolution. This review details both historical and current antimalarial drug discovery approaches. We also highlight new strategies that may be employed to discover resistance-resistant drug targets and chemotherapies in order to circumvent the rapid evolution of resistance in apicomplexan parasites.Pseudomonas aeruginosa is a Gram-negative pathogen
Like
Comment
Share
